Cambridgeshire and Peterborough
Formulary Chapter 3: Respiratory system -
Asthma guidance (BTS / Sign 2016)
Asthma inhaler devices (children under 5): NICE TA10
Asthma inhaler devices (older children): NICE TA38:
Bronchiectasis (non-CF) BTS guideline 2010
COPD guideline: NICE CG101
COVID-19: Use of high flow Oxygen therapy devices (including wall CPAP and high flow face mask or nasal oxygen) during the Coronavirus epidemic
CUH Early supported discharge (ESD) for patients with COPD
CUHFT: Respiratory: Asthma (adults)
Inhalers for Asthma and COPD: Supply Issues May 2020
National Patient Safety Alert 01/04/20: Interruption of high flow nasal oxygen during transfer
Nebuliser compatibilities (UKMI Q&A)
NHS England - Clinical guide for the management of palliative care in hospital during the coronavirus
NICE - COVID-19 rapid guideline: managing symptoms (including at the end of life) in the community [NG163]
BOC - Advice and support
BOC - Awareness and safety training
BOC - How to use a standard oxygen concentrator
BOC - How to use BOC home oxygen cylinders
BOC - How to use the transportable oxygen concentrator
BOC - Safety Information
BOC - Slips, trips and falls
BOC - Using the Inogen G3 portable oxygen concentrator
BOC Home Oxygen Portal Website
Section Title (top level)
Section Title (sub level)
First Choice item
Non Formulary section
Display tracking information
Link to adult BNF
Link to children's BNF
Link to SPCs
Scottish Medicines Consortium
High Cost Medicine
Cancer Drugs Fund
Traffic Light Status Information
Available Over the Counter. Consider Self Care
Formulary - Can be prescribed in both secondary and primary care.
Formulary - Specialist Advice, secondary care advice provided for primary care initiation.
Formulary - Specialist initiation without shared care guidance.
Formulary - Specialist initiation with shared care guidance.
Restricted - Hospital only, not to be prescribed in primary care.
Not recommended for prescribing. Switch to alternative cost-effective option.
Not recommended for prescribing in primary or secondary care.
Not recommended as no formal application made for addition to the formulary. Contact relevant pharmacy team for further information.
Non-Formulary (category under review).